Skip to main content
Toxins logoLink to Toxins
. 2020 Apr 22;12(4):270. doi: 10.3390/toxins12040270

Critical Comparison of Analytical Performances of Two Immunoassay Methods for Rapid Detection of Aflatoxin M1 in Milk

Ivan Pecorelli 1, Natascia Guarducci 2, Cristoph von Holst 3, Rita Bibi 1, Michelangelo Pascale 2, Biancamaria Ciasca 2, Antonio F Logrieco 2, Veronica M T Lattanzio 2,*
PMCID: PMC7232151  PMID: 32331441

Abstract

Aflatoxin B1 (AFB1) is a secondary metabolite produced by some Aspergillus spp. fungi affecting many crops and feed materials. Aflatoxin M1 (AFM1), the 4-hydroxylated metabolite of AFB1, is the main AFB1-related compound present in milk, and it is categorized by the International Agency for Research on Cancer (IARC) as a “group 1 human carcinogen”. The aim of this work was to evaluate and compare the analytical performances of two commercial immunoassays widely applied for the detection of AFM1 in milk, namely strip test immunoassay and enzyme linked immunosorbent assay (ELISA). Assay validation included samples at AFM1 levels of 25, 50, 75 ng/kg and blank samples (AFM1 < 0.5 ng/kg). With respect to a screening target concentration (STC) of 50 ng/kg the two assays showed cut-off values of 37.7 ng/kg and 47.5 ng/kg for strip test and ELISA, respectively, a false suspect rate for blanks <0.1% (for both assays) and a false negative rate for samples containing AFM1 at levels higher than STC, of 0.4% (for both assays). The intermediate precision (RSDip) was <32% for the strip test and <15% for the ELISA. Method verification through long-term intra-laboratory quality control (QC) measurements confirmed the results from the validation study. Furthermore, a satisfactory correlation of the results obtained with both immunoassays and the AOAC Official Method 2000.08 was obtained for the analysis of cow milk samples naturally contaminated with AFM1 at levels within “not detected” (< 0.5 ng/kg) and 50 ng/kg. Finally, the extension of the scope of the strip test method to goat and sheep milk was evaluated by applying the experimental design foreseen in the EU regulation.

Keywords: Aflatoxin M1, milk, strip test immunoassay, ELISA, method validation

1. Introduction

Aflatoxins are mycotoxins found in four main chemical structures: aflatoxin B1 (AFB1), B2 (AFB2), G1 (AFG1) and G2 (AFG2); they can occur in a wide range of crops, including the major staple cereals (e.g., maize), edible nuts and legumes and their products. The main fungal producers of aflatoxins are Aspergillus flavus which produces mainly AFB1, AFB2 and Aspergillus parasiticus, which produces all four forms. Contamination can occur before or after harvest or both. In general, AFB1 occurs at the highest levels compared to the others, and is the most toxic and a potent carcinogen [1,2]. AFB1 is converted into its hydroxylated metabolite (AFM1) by the liver enzymes of lactating animals [3]. This toxin, like the parent compound, has been categorized by the International Agency for Research on Cancer (IARC) as a group 1 toxin, a human carcinogen [2]. Due to their carcinogenity, the aflatoxins uptake through contaminated food consumption should be as low as possible, therefore the aflatoxin legislation is intended to implement the ALARA principle (As Low As Reasonably Achievable) and no threshold limit concerning the tolerable daily intake in humans has been established [4].

Evidences of aflatoxins carry over in milk, edible animal tissues and eggs have been reported, however, among foods of animal origin, milk represents the main source of human exposure to AFM1, which is the only mycotoxin which has regulatory limits in milk [4,5,6]. There is evidence of AFM1 occurrence in cow milk, but also in milk produced by other ruminants, such as buffalo, goat, sheep and camel [5]. The occurrence of AFM1 has been reported in various locations worldwide. Overall, the incidence of AFM1 in milk samples and milk products is relatively low in European countries, whereas data from Asian countries like China, Thailand and Taiwan show AFM1 occurrence in up to 100% of samples [7]. AFM1 is heat stable and processing or storage conditions are ineffective in reducing its concentration in milk and milk products [8,9,10]. Several factors may affect the AFM1 contamination of milk, such as environmental conditions, different farming and feeding practices, as well as the quality and safety control systems put in place by food/feed business operators (FBO) [9,11]. The presence of AFM1 in milk can be therefore considered as an indicator of maize chain vulnerability to fungal contamination [12].

Nowadays, there is an increasing concern for the impact of climate changes (temperature, humidity, rainfall and carbon dioxide production) on fungal behavior and consequently on aflatoxins production [11]. The application of predictive models has already given an indication of the potential increasing contamination by aflatoxins in Europe as consequence of climate changes [13]. Furthermore, a recent study using a full chain modeling approach to predict the impacts of climate change on AFB1 production in maize and its consequences on AFM1 contamination in dairy cow’s milk, showed that, in the investigated scenario (i.e., Ukrainian maize), AFM1 contamination in milk is expected to be comparable or to increase in future climate scenarios [14]. Therefore, according to EFSA definition, the presence of AFM1 in milk may be considered as an “emerging risk”, being a known risk for which an increasing and unpredictable pattern of exposure risk is foreseen [15].

Approximately 60 countries have already established regulatory limits for AFM1 in milk and dairy products [16]. In the EU, the maximum permitted levels for AFM1 have been set for consumable milk (50 ng/kg) [17]. In addition, an alert threshold level of 40 ng/kg calling for action is considered in some EU member states [18]. A maximum permitted level of 500 ng/kg of AFM1 in milk has been established by the US-FDA (United States Food and Drug Administration) [19] and by the Codex Alimentarius [20]. This is also the harmonized MERCOSUR limit applied in Latin America [16,21] and in several Asian countries [16].

With the publication of the General Food Law (GFL) [22] the European Union has made a new legal framework laying down the principles, obligations and definitions that apply in the field of food safety. A general principle of the GFL is that FBOs have the primary responsibility for food and feed safety. To this purpose, FBOs must implement a food safety management system, based on the hazard analysis and critical control point (HACCP) principles. Regulatory limits therefore have a strong impact on contracts and procedural guidelines in the dairy industry and, as consequence, on the number of controls needed to verify milk compliance with maximum permitted levels, which may affect production costs.

A wide range of methods for the detection of AFM1 in milk and dairy products is currently available, however, achieving key analytical performances, such as sensitivity, precision and reliability, suitable to enforce regulatory limits in the low ng/kg range, is still quite challenging [23]. Screening tests can play an important role within the safety monitoring, allowing rapid decision making and interventions, also affecting the final price of food products. Nowadays, screening tests based on immunochromatographic assays such as dipstick or lateral flow devices, and enzyme linked immunosorbent assays (ELISA) represent the most common formats in the market [24,25,26]. To support FBOs in selecting the most appropriate test in relation to the intended scope, internationally recognized guidelines for screening test performance verification have been made available for instance by the AOAC Research Institute (Performance Tested MethodsSM) and USDA-GIPSA (Performance Verified Rapid Test), whereas at European level, such guidelines are set in the Commission Decision 657/2002/EC [27] and in the Commission Regulation 2014/519/UE [28], which is specifically devoted to mycotoxin screening methods.

The aim of this work was to evaluate and compare the analytical performances of two commercial immunoassays (strip test immunoassay and ELISA) widely applied for the detection of AFM1 in milk. For this purpose, the Commission Regulation 2014/519/UE [28] was taken into consideration as guidance document. Analytical performances, such as precision profile, cut-off value, false positive and false negative rates were evaluated for each assay by single laboratory validation, whereas a verification of the results from the validation study was performed based on long-term intra-laboratory quality control (QC) data. Correlation of the results obtained with the rapid immunoassays and the AOAC Official Method 2000.08 was evaluated for the analysis of naturally contaminated cow milk samples. Finally, the extension of the scope of the strip test method to goat and sheep milk was evaluated by applying the experimental design foreseen in the EU regulation [28].

2. Results and Discussion

The experimental design to evaluate analytical performances of strip test immunoassay and ELISA comprised the following steps, which were carried out in parallel for the two assays: i) single laboratory validation study to evaluate precision, cut-off value, false suspect and false negative rates (milk samples fortified by AFM1 were used at this stage); ii) verification of cut-off and precision values by long-term intra-laboratory QC study (a QC cow milk sample spiked at 50 ng/kg was used at this stage); iii) evaluation of results correlation between rapid immunoassays and AOAC Official Method 2000.08 (a set of naturally contaminated cow milk samples was used for this purpose). Data obtained for each step are described and discussed in the following.

2.1. Validation Results

Validation experiments were performed according to the experimental design described in Section 4.6. The screening target concentration (STC) value was 50 ng/kg. Other tested mass fractions values were: blank (AFM1 ≤ 0.5 ng/kg), 25 ng/kg (50% of the STC), 75 ng/kg (150% STC). The same sample set was analyzed by the ELISA and the strip test. Results obtained from the 24 measurements performed for each validation level were taken as basis for the calculation of validation parameters: precision, cut-off value, false positive and false negative rate. The overall results of the statistical assessment are shown in Table 1.

Table 1.

Analytical performances of the strip test immunoassay and enzyme linked immunosorbent assay (ELISA), as resulted by validation experiments.

Test Sample Strip Test ELISA
Blank
(AFM1 ≤ 0.5 ng/kg)
Mean response (ng/kg) 4.2 8.2
RSDr (%)1 93 16
RSDip (%)2 140 33
False suspect rate (%) <0.1 <0.1
50% STC
(25 ng/kg)
Mean response (ng/kg) 23.2 30.7
RSDr (%) 26 5
RSDip (%) 32 5
False suspect rate (%) 3 <0.1
STC
(50 ng/kg)
Mean response (ng/kg) 53.1 57.9
RSDr (%) 12 5
RSDip (%) 17 10
150% STC
(75 ng/kg)
Mean response (ng/kg) 85.6 105
RSDr (%) 16 15
RSDip (%) 19 15
False negative rate (%) 0.4 0.1
Cut-off value (ng/kg) 37.7 47.5

1 RSDr relative standard deviation of the repeatability; 2 RSDip relative standard deviation for intermediate precision.

First, precision data were calculated for all tested concentrations. Specifically, RSDip (intermediate precision) values of 32% (strip test) and 5% (ELISA) were obtained for samples contaminated at 25 ng/kg, values of 17% (strip test) and 10% (ELISA) at 50 ng/kg, 19% (strip test) and 15% (ELISA) at 75 ng/kg. Repeatability values (RSDr) were lower than 26% in all cases. Comparable values were obtained for the two tests at STC and above STC, whereas at 50% STC (25 ng/kg) lower intermediate precision values where obtained for ELISA. This could be partially explained by the fact that ELISA was working at a level five times higher than its limit of detection (LOD, 5 ng/kg, see Section 4.4), whereas the strip test was working at its LOD (25 ng/kg see Section 4.3).

With respect to the blank samples, a high relative standard deviation of the strip test response was observed. This could be mainly explained by the fact that for the strip test assay analytical signal values below a certain fixed limit, which is set by the manufacturer, are reported as “zero concentration”, whether that is true or not. This led to a high number of “zero concentration” values in blank samples generating a high standard deviation. However, in the following, it will be shown that, notwithstanding this high value, an acceptable low rate of false suspect results for the blank samples was obtained anyway, due to the good separation of test responses for blank and contaminated samples.

Overall, the obtained precision values indicated an acceptable robustness of the two test methods, also taking into consideration the very low target levels of AFM1 considered for validation.

Once intermediate precision data were available, it was possible to calculate the cut-off values. According to European legislation [28], this value is defined as the response (AFM1 mass fraction) obtained with the screening method, “above which the sample is classified as suspect”, with a false negative rate of 5%. The calculated cut-off values were 37.7 ng/kg for the strip test and 47.5 ng/kg for the ELISA test, respectively. In both cases, the assay sensitivity was considered satisfactory for assessing milk contamination at levels encompassing the EU maximum limits.

Based on the cut-off values, the rate of false suspect results was estimated for samples containing AFM1 below the STC. Specifically, for samples contaminated at 50% STC (25 ng/kg) the false suspect rate was 3% for the strip test and < 0.1% for the ELISA test. Finally, the false negative rate for samples contaminated at levels above the STC (75 ng/kg in the present case) resulted to be 0.4% for strip test and 0.1% for ELISA. In both cases, the acceptability criterion of maximum 5% false negative rate was met.

The overall results indicated satisfactory kits reliability in discriminating samples contaminated at different AFM1 levels set in a very narrow working range (from ≤ 0.5 to 75 ng/kg), encompassing EU regulatory limits.

In addition, the method fitness for purpose of evaluating milk contamination at the alert threshold of 40 ng/kg was evaluated by analyzing 20 contaminated samples from two different farms. The obtained average responses were 40.0 ng/kg for the strip test and 40.2 for the ELISA, with relative standard deviation (RSDip) of 9.8% and 5.8%, respectively. The resulting cut-off levels were 33.2 ng/kg and 36.1 ng/kg. No false suspect samples resulted for blanks with respect to these cut-off values. These data demonstrated the fitness for purpose of the two tested kits in evaluating compliance of milk samples with respect to the alert threshold of 40 ng/kg.

2.2. Verification of Method Performances through Quality Control Data

Verification of method performances was carried out through long-term intra-laboratory QC measurements over a period of 12 months (see Section 4.6). The results of the validation and the verification study were compared in terms of precision, recovery rates and cut-off values, as shown in Table 2. The cut-off values calculated by QC data matched very well with those obtained by validation data. Moreover, the data from the validation study as well as from the QC exercise revealed comparable values for the precision and the recovery rate, thus demonstrating sufficient ruggedness of both methods over the time and different production lots.

Table 2.

Verification of strip test and ELISA method performances though quality control (QC) data.

Method Performances Strip Test ELISA
Single Lab validation QC Single Lab validation QC
STC
(50 ng/kg)
Mean response (ng/kg) 53.1 53.5 57.9 52.8
Relative recovery rate (%) 106 107 116 106
RSDip (%)1 17 12 10 9.2
Cut-off value (ng/kg) 37.7 42.7 47.5 44.7

1 RSDip relative standard deviation for intermediate precision.

2.3. Analysis of Naturally Contaminated Samples

The trueness of data generated by the two screening methods was evaluated by comparing them with results obtained by the reference AOAC Official Method 2000.08 on a set of raw cow milk samples naturally contaminated in the range n.d. (≤0.5 ng/kg) – 50 ng/kg AFM1.

Results are depicted in Figure 1. The two test kits performed in a similar way, and in both cases a satisfactory correlation was observed, with results provided by the reference method (r = 0.923 and slope = 0.84 for strip test vs HPLC and r = 0.924 and slope = 1.05 for ELISA vs HPLC). Irrespective of a slight overestimation of the AFM1 content in some of the blank samples (HPLC result ≤ 0.5 ng/kg), both immunoassays returned values lower than 14 ng/kg, confirming the absence of false suspect results.

Figure 1.

Figure 1

Correlation between results (AFM1 mass fraction, ng/kg) obtained by strip test or ELISA and the HPLC analysis performed according to the AOAC Official Method 2000.08.

2.4. Extension of Scope of the Method to Other Commodities

Finally, the extension of the scope of the strip test method to goat and sheep milk was evaluated by applying the experimental design foreseen in the EU regulation. The regulation foresees that “as long as the new commodity belongs to a commodity group (“milk” in the present case) for which an initial validation has already been performed, a minimum of 10 homogeneous negative control and 10 homogeneous positive control (at STC) samples shall be analyzed under intermediate precision conditions. The positive control samples shall all be above the cut-off value as calculated in validation experiments.

For these purposes, first specific calibration curves (bar codes) were generated for strip test analysis of raw goat and raw sheep milk. Then 10 blank (negative) samples and 10 samples contaminated by AFM1 at 50 ng/kg were analyzed for each milk type. An additional sample set containing AFM1 at 25 ng/kg was also included. Results are reported in Figure 2. In both cases negative samples were correctly classified as below the cut-off. No false suspect was reported. In addition, samples contaminated at 50% STC (25 ng/kg) were all correctly classified as below the cut-off (Table 1) and no false suspect was reported. All samples contaminated at 50 ng/kg (STC) were correctly classified above the cut-off.

Figure 2.

Figure 2

Results of strip test analysis of blank sheep and goat milk samples and samples contaminated with 25 and 50 ng/kg AFM1.

The obtained data showed the applicability of the strip test immunoassay to goat and sheep milk provided that a specific calibration curve was used.

2.5. Fitness for Purpose of the Validated Immunoassays

Validation experiments returned, for both immunoassays, fit for purpose analytical performances such as cut-off values (37.7 ng/kg and 47.5 ng/kg for strip test and ELISA respectively), false suspect rate for blanks (<0.1% for both assays) and false negative rate (<0.4% (for both assays). Both assays showed an intermediate precision at STC (50 ng/kg) <17% either in validation and QC measurements. However, besides analytical performances, when choosing a method for rapid mycotoxin screening, the concept of fitness for purpose also includes some practical parameters. Factors such as the time needed for analysis, the skills or level of education of the user of the method and the place where the analysis needs to be carried out are generally taken into consideration by the end users. A more comprehensive comparison of performances of mycotoxin screening tests can be found in Lattanzio et al. [29]. In the present case, the total analytical time for strip test assay was about 10 min and the use of the incubator, as well as the portable reader, made it suitable for on farm use. The ELISA involved more steps, a basic laboratory equipment and more time (approx 80 min). On the other hand, ELISA tests allow to handle up to 48 samples simultaneously (including calibrants and QC samples), while the strip test foresees only one sample per analysis/strip. ELISA can be therefore more efficient when a large number of (sub)samples need to be analyzed in a short period of time. On the other hand, when applied in routine by experienced technicians, strip testing can be stacked to process multiple samples in a relatively short period of time, by processing 10 to 15 samples 1 min apart. Finally, concerning method transferability to unskilled personnel, the strip test appears easier to be applied by low experienced technicians, not only because the analytical protocol is less laborious, but also because the automatic calibration via QR code uploading. In principle both platforms are potentially suitable for multiplexing [30,31,32].

3. Conclusions

Analytical performances and fitness for purpose of two commercial immunoassays widely applied for the detection of AFM1 in milk (strip test and ELISA) were evaluated, according to guidelines set in Regulation 519/2014/EU. Both assays showed satisfactory performances in terms of precision, recovery rates, false positive and false negative rates. In addition, the method performance profiles of the two methods obtained in the validation study could be verified by long-term intra-laboratory QC data. A good correlation between the results provided by the validated assays and the AOAC reference method was observed when analyzing naturally contaminated samples. The extension of the scope of the strip test method to goat and sheep milk was successfully evaluated by applying the experimental design foreseen in the EU regulation.

4. Materials and Methods

4.1. Materials

Methanol and acetonitrile (HPLC grade) were purchased from Mallinckrodt Baker (Milan, Italy). Ultrapure water was produced by using a Millipore Milli-Q system (Millipore, Bedford, MA, USA). AflaM1 Test immunoaffinity columns were from VICAM (A Waters Business, Milford, MA, USA). Paper Filters (Whatman 4) were obtained from Whatman International Ltd. (Maidstone, UK). Standard aflatoxin M1 (acetonitrile solution 10 µg/mL) was purchased from Supelco (Bellefonte, PA, USA).

4.2. Milk Samples

Milk samples (cow, sheep, goat) were collected from farm bulk tanks from Italian farmers in the time span 2018–2019. After collection samples were stored at 4 °C and analyzed within 48 h.

Fortified milk samples to be used for validation (Section 4.6) were prepared as follows. A spiking solution containing AFM1 at 1 µg/mL was prepared by diluting 10 times the standard AFM1 solution. Then 25 µL of spiking solution were added to 50 mL of milk to prepare a mother solution at 500 ng/kg AFM1. The mother solution was diluted by appropriate volumes of milk to obtain contaminated samples at 75, 50, 40 and 25 ng/kg.

4.3. Strip Test Immunoassay

The strip test (AFLAM1-V™), incubator, and a photometric reader (Vertu Reader) were from VICAM (A Waters Business, Milford, MA, USA). The strip test format is based on an indirect competitive immunoassay. Line intensities developed on the strip membrane (test line and control line) are measured using the photometric reader. The test response is the ratio between the signal intensity of the test line and that of the control line and it is converted into toxin concentration through a lot specific calibration curve.

Strip test analyses of milk samples were performed as follows. Two hundred microliters of cold milk were pipetted into the reagent vial. After vortex mixing (3 times x 5 sec) the vial was placed into the incubator set at 40 °C and the strip was inserted into it. The sample was allowed to migrate onto the strip for to 10 min, then the strip was placed into the reader holder for result reading. The lot specific calibration curve was uploaded onto the reader system by using the corresponding barcode provided by the supplier. The calibration curve was generated by spiking uncontaminated milk (cow, sheep or goat milk) at seven AFM1 levels over the range 0–800 ng/kg, performing triplicate measurements for each calibration level. The limit of detection declared by the supplier was 25 ng/kg.

4.4. Enzyme Linked Immunosorbent Assay

The ELISA kit (I’Screen AflaM1) was from Eurofins Technologies (Budapest, Hungary). Calibration standards, conjugate, antibody and substrate/chromogen solutions were provided in the kit. The plate reader was Multiskan MS Plus MK II ELISA reader from Labsystems (Helsinki, Finland).

Samples were analyzed as follows. One hundred microliters of milk (or calibrant solution) were transferred into the well and incubated for 45 min at room temperature. After discarding the liquid by turning the plate upside down, the wells were filled completely with the working wash solution. Then the liquid was poured out from wells and the remaining drops were removed by tapping the microplate upside down against adsorbent paper. This washing sequence was repeated four times. Then 100 µL of AFM1-enzyme conjugate solution were added and incubated for 15 min. After discarding the liquid, the wells were washed four times, according to the above described procedure. Then, 100 µL of substrate solution were added and incubated for 15 min for color development. Finally, 50 µL of stop solution were added. Result were read measuring the absorbance at 450 nm. The limit of detection declared by the supplier was 5 ng/kg.

4.5. Reference Method (AOAC Official Method 2000.08)

Screening for blank samples to be used for validation experiments and strip test calibration curve generation, and analysis of naturally contaminated samples for method comparison purposes were performed, according to the AOAC Official Method 2000.08, with minor modifications. Briefly, milk samples (50 mL) were centrifuged at 2000× g to separate the fat. After discarding the upper thin fat layer, the sample was filtered through paper filter. The filtered sample (25 mL) was passed through the immunoaffinity column. The eluate was discarded and the column was washed twice with 10 mL distilled water. The toxin was eluted by 2 × 1 mL methanol. The eluate was collected and dried down under nitrogen stream. The residue was re-dissolved with 250 µL of a mixture water:acetonitrile (75:25 by vol).

HPLC-FD analyses were performed on an Agilent 1100 Series chromatographic system (Agilent Technologies, Palo Alto, CA, USA) equipped with a fluorometric detector (model 363), and the ChemStation data software (Agilent Technologies). The analytical column was a Zorbax SB-C18 Rapid Resolution HT (4.6 mm × 50 mm, 1.8 µm) with corresponding in-line filter. The chromatographic separation was performed by a gradient elution using water (solvent A) and acetonitrile (solvent B). The flow rate of the mobile phase was 1 mL/min. The injection volume was 50 µL. The column was kept at a temperature of 40 °C; the excitation wavelength was set at 365 nm and the emission wavelength was set at 435 nm. The detection limit was 0.5 ng/kg.

4.6. Validation Design and Verification Study via Qualitity Control (QC) Measurements

The single laboratory validation study was designed to fulfil the specifications established in Commision Regulation (EU) 519/2014, in terms of minimum sample set and minimum number of validation levels.

Measurements were distributed in two different days (instead of 5 as suggested in the regulation, due to the limited stability of milk samples). Milk samples were from three different farms. In addition, each sample was analyzed in quadruplicate each day under repeatability conditions. The design resulted in 12 independent analysis per day and 24 measurements in total per each validation level.

The screening target concentration (STC) was set at the EU maximum permitted level of 50 ng/kg. The selected validation levels were four: blank (i.e., <0.5 ng/kg), and samples spiked by 25 ng/kg (50% STC), 50 ng/kg (STC), 75 ng/kg (150% STC) of AFM1. An additional sample set containing AFM1 at 40 ng/kg was included to evaluate the fitness for purpose of the two tested methods in high risk periods when it is recommended to set the alert threshold (STC) at 40 ng/kg [18].

The results of analysis were then subjected to statistical assessment to calculate validation parameters as described in the following.

Verification of method performances was carried out through long-term intra-laboratory QC measurements. For both assays, 50 measurements of the QC material, i.e., raw cow milk spiked at STC (50 ng/kg), were spread over a period of 12 months. Moreover, 4 different kit lots were used for the strip test and 6 different lots for the ELISA test, thus including additional factors in the verification study, which may have an impact on the result of analysis. Finally, the results of these analysis were taken as a basis for the calculation of the cut-off values, precision and recovery rates.

4.6.1. Precision

To evaluate the precision profile of the method, data generated each validation level were subjected to analysis of variance (ANOVA). When applying this model, as defined by ISO 5725 [33], the measured test response Yijk (the AFM1 mass fraction in the present case) is defined as the true value (TV) plus the contribution of 3 components:

Yijk = TV + Di + Mij +Rijk (1)

where Di is the between-day variability, Mij is the between-matrix (milk batches from different farms) variability, and Rijk is the within-day variability. The within-day variability gives the precision under repeatability conditions, whereas the sum of all components gives the intermediate precision. The statistical assessment was done with the software package MINITABTM Statistical Software for Windows (Version 15).

4.6.2. Cut-Off Value

The measured levels (ng/kg) of samples containing AFM1 at STC were taken as basis for the calculation of the cut-off value. According to Regulation 519/2014/EU the following equation was used:

Cut off=RSTCtvalue(0.05)×SDSTC (2)

where the RSTC is the mean level of AFM1 (ng/kg) calculated from all 24 experiments performed on samples containing AFM1 at STC, SDSTC is the corresponding standard deviation of intermediate precision as defined in the previous paragraph, and tvalue(0.05) is the one tailed t value for a rate of false negative results of 5%.

4.6.3. False Suspect and False Negative Rate

Using the cut-off value and the results from the analysis of negative samples the rate of false suspect results was estimated by first calculating the t-value as follows:

tvalue=(cut offmeanneg)SDneg (3)

where meanneg is the mean value of the results obtained from the 24 experiments on the negative samples and SDneg is the corresponding standard deviation of intermediate precision.

From the obtained t-value, based on the degrees of freedom calculated from the number of experiments (23 in the present case), the false suspect rate results (probability) for a one tailed distribution was calculated using the spread sheet function “TDIST” from Microsoft Excel.

The false suspect rate for samples containing AFM1 at 50% STC was calculated by applying the same procedure using the mean value of the results obtained from the 25 experiments on samples containing AFM1 at 50% STC and the relevant standard deviation of intermediate precision.

Finally, the false negative rate for samples containing AFM1 at levels above the STC was estimated by calculating the t value as specified here:

tvalue=(mean>STCcutoff)SD>STC (4)

where mean>STC is the mean value of the results obtained from the experiments on the samples containing the analyte above the STC, cut-off is the value established as above, and SD>STC is the corresponding standard deviation of the intermediate precision. The probability corresponding to the calculated t value with a one-tailed distribution gives the rate of false negative results for the samples containing the analyte at levels higher than STC.

Author Contributions

Conceptualization, V.M.T.L. and C.v.H.; methodology, V.M.T.L. and I.P.; formal analysis and validation, N.G., R.B. and B.C.; statistics, C.v.H.; writing—original draft preparation, V.M.T.L., I.P.; writing—review and editing, supervision, V.M.T.L., M.P. and A.F.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

Key Contribution

The study provides insights about the process of evaluating and comparing the performance profile of rapid methods currently applied for AFM1 screening in milk. Addressing EU official guidelines, the fitness for purpose of strip test and ELISA based methods was evaluated, including verification of method performances through long-term quality control measurements and comparison with the AOAC reference method.

References

  • 1.WHO-FAO Evaluation of Certain Food Additives and Contaminants, Sixty-Eighth Report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 947. [(accessed on 20 April 2020)]; Available online: http://apps.who.int/iris/bitstream/10665/43870/1/9789241209472_eng.pdf.
  • 2.International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans: Chemical Agents and Related Occupations. A Review of Human Carcinogens. Volume 100F. [(accessed on 20 April 2020)]; Available online: http://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Chemical-Agents-And-Related-Occupations-2012.
  • 3.Marchese S., Polo A., Velotto S., Costantini S., Severino L. Aflatoxin B1 and M1: Biological properties and their involvement in cancer development. Toxins. 2018;10:214. doi: 10.3390/toxins10060214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.WHO-FAO Safety Evaluation of Certain Contamimants in Food. Eighty-Third Meeting of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 74. [(accessed on 17 April 2020)]; Available online: https://apps.who.int/iris/handle/10665/276868.
  • 5.European Food Safety Authority (EFSA) Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to Aflatoxin B1 as undesirable substance in animal feed. EFSA J. 2004;39:1–27. doi: 10.2903/j.efsa.2004.39. [DOI] [Google Scholar]
  • 6.Völkel I., Schröer-Merker E., Czerny C.P. The carry-over of mycotoxins in products of animal origin with special regards to its implications for the European food safety legislation. Food Nutr. Sci. 2011;2:852–867. doi: 10.4236/fns.2011.28117. [DOI] [Google Scholar]
  • 7.Becker-Algeri T.A., Castagnaro D., De Bortoli K., De Souza C., Drunkler A., Badiale-Furlong E. Mycotoxins in bovine milk and dairy products: A review. J. Food Sci. 2016;81:R544–R552. doi: 10.1111/1750-3841.13204. [DOI] [PubMed] [Google Scholar]
  • 8.WHO-FAO Safety Evaluation of Certain Mycotoxins in Food—Prepared by the 56th meeting of the JECFA (Joint FAO/WHO Expert Committee on Food Additives)—FAO Food and Nutrition Paper 74/WHO Foods Additives Series 47. [(accessed on 20 April 2020)]; Available online: http://www.inchem.org/documents/jecfa/jecmono/v47je01.htm.
  • 9.Prandini A., Tansini G., Sigolo S., Filippi L., Laporta M., Piva G. On the occurrence of aflatoxin M1 in milk and dairy products. Food Chem. Toxicol. 2009;47:984–991. doi: 10.1016/j.fct.2007.10.005. [DOI] [PubMed] [Google Scholar]
  • 10.Campagnollo F.B., Ganev K.C., Khaneghah A.M., Portela J.B., Cruz A.G., Granato D., Corassin C.H., Oliveira C.A.F., Sant’Ana A.S. The occurrence and effect of unit operations for dairy products processing on the fate of aflatoxin M1: A review. Food Control. 2016;68:310–329. doi: 10.1016/j.foodcont.2016.04.007. [DOI] [Google Scholar]
  • 11.Miliĉeviĉ D., Petronijeviĉ R., Petroviĉ Z., Đjinoviĉ-Stojanoviĉ J., Jovanoviĉ J., Baltiĉ T., Janković S. Impact of climate change on aflatoxin M1 contamination of raw milk with special focus on climate conditions in Serbia. J. Sci. Food Agric. 2019;99:5202–5210. doi: 10.1002/jsfa.9768. [DOI] [PubMed] [Google Scholar]
  • 12.Frazzoli C., Gherardi P., Saxena N., Belluzzi G., Mantovani A. The hotspot for (global) one health in primary food production: Aflatoxin M1 in dairy products. Front. Public Health. 2017;4 doi: 10.3389/fpubh.2016.00294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Battilani P., Rossi P., Giorni A., Pietri A., Gualla H.J., van der Fels-Klerx C.J.H., Booij A., Moretti A., Logrieco A., Miglietta F., et al. Modelling, predicting and mapping the emergence of aflatoxins in cereals in the EU due to climate change. EFSA Supporting Publ. 2012;9 doi: 10.2903/sp.efsa.2012.EN-223. [DOI] [Google Scholar]
  • 14.Van der Fels-Klerx H.J., Vermeulen L.C., Gavai A.K., Liu C. Climate change impacts on aflatoxin B1 in maize and aflatoxin M1 in milk: A case study of maize grown in Eastern Europe and imported to the Netherlands. PLoS ONE. 2019;14:e0218956. doi: 10.1371/journal.pone.0218956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.EFSA Definition and Description of “Emerging Risks”. [(accessed on 20 April 2020)]; Available online: https://www.efsa.europa.eu/en/topics/topic/emerging-risks.
  • 16.Food and Agriculture Organization of the United Nations Worldwide Regulations for Mycotoxins in Food and Feed in 2003. Food and Nutrition Paper No. 81. [(accessed on 20 April 2020)]; Available online: http://www.fao.org/3/y5499e/y5499e00.htm.
  • 17.European Commission Commission Regulation (EC) No 401/2006 of 23 February 2006 laying down the methods of sampling and analysis for the official control of the levels of mycotoxins in foodstuffs. Off. J. Eur. Commun. 2006;L364:5–24. [Google Scholar]
  • 18.Italian Ministry of Health Nota del Ministero della Salute prot. n. 855 del 16/1/2013—Aflatossine. Extraordinary Operating Procedures for the Prevention and Management of the Risk of Aflatoxin Contamination in the Dairy Supply Chain and in the Production of Maize Destined for Human and Animal Nutrition, Following Extreme Weather Conditions. [(accessed on 20 April 2020)]; Available online: http://www.unionalimentari.com/website/law.aspx?id=1287&key=&fl=
  • 19.Food and Drug Administration CPG Sec 527.400 Whole Milk, Lowfat Milk, Skim Milk—Aflatoxin M1. [(accessed on 20 April 2020)]; Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cpg-sec-527400-whole-milk-lowfat-milk-skim-milk-aflatoxin-m1.
  • 20.Codex Alimentarius General Standard for Contaminants and Toxins in Food and Feed (CODEX STAN 193-1995) Adopted in 1995 Revised in 1997, 2006, 2008, 2009 Amended in 2010, 2012, 2013, 2014, 2015. [(accessed on 20 April 2020)]; Available online: http://www.fao.org/fao-who-codexalimentarius/codex-texts/all-standards/en/
  • 21.Agencia Nacional de Vigilancia Sanitaria (ANVISA), Brazil Resoluçao RDC n_7, de 18 de Fevereirode 2011. Regulamento Tecnico Sobre Limites Maximos Tolerados (LMT) para Micotoxinas em Alimentos. [(accessed on 20 April 2020)]; Available online: http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2011/res0007_18_02_2011_rep.html.
  • 22.European Commission Commission Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. Off. J. Eur. Commun. 2002;L31:1–24. [Google Scholar]
  • 23.Vaz A., Cabral Silva A.C., Rodrigues P., Venâncio A. Detection methods for aflatoxin M1 in dairy products. Microorganisms. 2020;8:246. doi: 10.3390/microorganisms8020246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Li W., Powers S., Dai S.Y. Using commercial immunoassay kits for mycotoxins: ‘joys and sorrows’? World Mycotoxin J. 2014;7:417–430. doi: 10.3920/WMJ2014.1715. [DOI] [Google Scholar]
  • 25.Matabaro E., Ishimwe I., Uwimbabazi E., Lee B.H. Current immunoassay methods for the rapid detection of aflatoxin in milk and dairy products. Compr. Rev. Food Sci. Food Saf. 2019;16:808–820. doi: 10.1111/1541-4337.12287. [DOI] [PubMed] [Google Scholar]
  • 26.Nolan P., Auer S., Spehar A., Elliott C.T., Campbell K. Current trends in rapid tests for mycotoxins. Food Addit. Contam. Part A. 2019;36:800–814. doi: 10.1080/19440049.2019.1595171. [DOI] [PubMed] [Google Scholar]
  • 27.European Commission Commission Decision (EC) No 657/2002 of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Commun. 2002;L221:8–36. [Google Scholar]
  • 28.European Commission Commission Regulation (EU) No 519/2014 of 16 May 2014 amending Regulation (EC) No 401/2006 as regards methods of sampling of large lots, spices and food supplements, performance criteria for T-2, HT-2 toxin and citrinin and screening methods of analysis. Off. J. Eur. Commun. 2014;L147:29–43. [Google Scholar]
  • 29.Lattanzio V.M.T., Von Holst C., Lippolis V., De Girolamo A., Logrieco A.F., Mol H.G.J., Pascale M. Evaluation of mycotoxin screening tests in a verification study involving first time users. Toxins. 2019;11:129. doi: 10.3390/toxins11020129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lattanzio V.M.T., Nivarlet N., Lippolis V., Della Gatta S., Huet A.C., Delahaut P., Granier B., Visconti A. Multiplex dipstick immunoassay for semi-quantitative determination of Fusarium mycotoxins in cereals. Anal. Chim. Acta. 2012;718:99–108. doi: 10.1016/j.aca.2011.12.060. [DOI] [PubMed] [Google Scholar]
  • 31.Maragos C.M. Multiplexed biosensors for mycotoxins. J. AOAC Int. 2016;99:849–860. doi: 10.5740/jaoacint.16-0112. [DOI] [PubMed] [Google Scholar]
  • 32.Plotan M., Devlin R., Porter J., Benchikh M., Rodríguez M.L., McConnell R.I., Fitzgerald S.P. The use of biochip array technology for rapid multimycotoxin screening. J. AOAC Int. 2016;99:878–888. doi: 10.5740/jaoacint.16-0115. [DOI] [PubMed] [Google Scholar]
  • 33.ISO . Accuracy (Trueness and Precision) of Measurement Methods and Results—Part 3: Intermediate measures of the Precision of a Standard Measurement Method. ISO Standards; Geneva, Switzerland: 1994. ISO 5725–3; ICS 03.120.30. [Google Scholar]

Articles from Toxins are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES